logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
F

Florent Peyraud

Institut national de la santé et de la recherche médicale
H指数:16
被引数:1,116

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunosuppressive myeloid cells induce mesenchymal-like breast cancer stem cells by a membrane-bound TGF-β1-dependent mechanism

免疫抑制性髓系细胞通过膜结合TGF-β1依赖机制诱导间充质样乳腺癌干细胞

Cell Reports
IF6.9
2026-06-010
PRE
Boyer, Thomas; Blaye, Celine; Chalopin, Domitille; Madery, Mathilde; Boucher, Jonathan; Moisand, Alexandra; Theodoly-Lannes, Audrey; Giraud, Julie; Peyraud, Florent; Seeneevassen, Lornella; Klein, Clement; Mebroukine, Samy; Auriol, Sophie; Chaibi, Assia; Zouine, Atika; Izotte, Julien; Charrot, Lea Mora; Alizadeh, Darya; Iggo, Richard; MacGrogan, Gaetan; Lamarthee, Baptiste; Bonnotte, Bernard; Bonneil, Eric; Roux, Philippe P.; Varon, Christine; Domblides, Charlotte; Larmonier, Nicolas
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab

用抗血管生成药物重塑冷软组织肉瘤的肿瘤微环境: regorafenib联合avelumab的2期试验

Signal Transduction and Targeted Therapy
IF52.7
2025-06-270
OA
Maud Toulmonde; Jean-Philippe Guégan; Mariella Spalato-Ceruso; Thibaud Valentin; Rastilav Bahleda; Florent Peyraud; Christophe Rey; Michèle Kind; Coralie Cantarel; Carine Bellera; Lucile Vanhersecke; Alban Bessede; Antoine Italiano
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
ANNALS OF ONCOLOGY
IF65.4
2023-04-0132
OAAI
Bayle, A.; Belcaid, L.; Aldea, M.; Vasseur, D.; Peyraud, F.; Nicotra, C.; Geraud, A.; Sakkal, M.; Seknazi, L.; Cerbone, L.; Blanc-Durand, F.; Hadoux, J.; Mosele, F.; Tagliamento, M.; Bernard-Tessier, A.; Verret, B.; Smolenschi, C.; Clodion, R.; Auger, N.; Romano, P. M.; Gazzah, A.; Camus, M. N.; Micol, J.; Caron, O.; Hollebecque, A.; Loriot, Y.; Besse, B.; Lacroix, L.; Rouleau, E.; Ponce, S.; Soria, J. C.; Barlesi, F.; Andre, F.; Italiano, A.
Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)
ANNALS OF ONCOLOGY
IF65.4
2022-12-0125
OA
Bayle, A.; Peyraud, F.; Belcaid, L.; Brunet, M.; Aldea, M.; Clodion, R.; Dubos, P.; Vasseur, D.; Nicotra, C.; Geraud, A.; Sakkal, M.; Cerbone, L.; Blanc-Durand, F.; Mosele, F.; Romano, P. Martin; Camus, M. Ngo; Soubeyran, I.; Khalifa, E.; Alame, M.; Blouin, L.; Dinart, D.; Bellera, C.; Hollebecque, A.; Ponce, S.; Loriot, Y.; Besse, B.; Lacroix, L.; Rouleau, E.; Barlesi, F.; Andre, F.; Italiano, A.

研究方向

暂未获取到该数据
A
Antoîne Italiano
H 指数:99论文数:1,422被引数:4.5万
J
Jean‐Philippe Guégan
H 指数:22论文数:134被引数:2,250
A
Alban Bessede
H 指数:32论文数:203被引数:5,047
M
Mariella Spalato Ceruso
H 指数:17论文数:98被引数:1,076
L
Lucile Vanhersecke
H 指数:10论文数:54被引数:1,017
M
Maud Toulmonde
H 指数:41论文数:283被引数:9,966
S
Sophie Cousin
H 指数:35论文数:405被引数:5,068
F
François Le Loarer
H 指数:41论文数:262被引数:7,819
C
Charlotte Domblides
H 指数:18论文数:103被引数:1,578
C
Christophe Rey
H 指数:7论文数:61被引数:283